
Round Table event
Innovation in Life Sciences – CCO round table
Location
London
Date
12th September 2024
Compass Carter Osborne welcomed a cohort of Life Sciences industry leaders to discuss where the next big innovation in the Life Sciences sector is coming from.
Key areas of discussion covered off:
- Which innovations might have the biggest positive impact on the sector in the next five years
- Investor standpoint: which technologies are you most likely to invest in, and why?
- Quantum Computing – hype or hope?
- What can the Life Sciences sector do to ensure the potential for innovation through computing is delivered?
- Biotech funding cycle bounce-back
- Therapeutic or devices in 2025 – target markets
With thanks to guests for their insights and contributions:
- Geoff Dobson (Discussion Chair)
- Matthew Fyfe, Storm Therapeutics
- Prashant Shah, O2h Discovery
- Dr Iris Good, Plural
- Jerry Wu, TusPark Holdings
- Aline Charpentier, Bruntwood SciTech
- Sebastian Stachowiak, ICE Biopharma
- Colin Sims, Adthera Bio
- Dr Suhail Nurbhai, Mission Therapeutics
- Usman “Oz” Azam, Inspirna
- Stephen Dowd, Confo Therapeutics
- Tarquin Bennett-Coles, Compass Carter Osborne
- Martin Anderson, Carrot Recruitment
- Alex Boulger, Compass Carter Osborne